Monocyte telomere shortening and oxidative DNA damage in type 2 diabetes

Mike J Sampson1, Mark S Winterbone, Jackie C Hughes

  • 1Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital National Health Service Trust, Norwich NR4 7UA, UK. mike.sampson@nnuh.nhs.uk

Diabetes Care
|January 31, 2006
PubMed
Abstract

Insights

Type 2 diabetes is linked to shorter telomeres in monocytes, potentially due to increased oxidative DNA damage. This cellular aging may contribute to vascular complications in diabetic patients.

Area of Science:

  • Cellular and Molecular Biology
  • Endocrinology
  • Gerontology

Background:

  • Telomeres, protective DNA caps, shorten with cell division and oxidative stress.
  • Replicative senescence, triggered by critically short telomeres, is a hallmark of aging.
  • Type 2 diabetes is associated with increased oxidative DNA damage, suggesting a potential link to telomere attrition.

Purpose of the Study:

  • To investigate whether telomere shortening characterizes type 2 diabetes.
  • To explore the relationship between telomere length, oxidative DNA damage, and metabolic markers in type 2 diabetes.

Main Methods:

  • Compared telomere length in monocytes and T-cells between 21 male type 2 diabetic subjects and 29 matched controls.
  • Measured oxidative DNA damage using flow cytometry.
  • Assessed peripheral insulin resistance and high-sensitivity C-reactive protein (hsCRP).

Main Results:

  • Monocyte telomere length was significantly shorter in diabetic subjects compared to controls (P < 0.0001).
  • No significant difference in lymphocyte telomere length was observed.
  • A significant inverse correlation between oxidative DNA damage and telomere length was found in diabetic individuals (r = -0.55; P = 0.018).

Conclusions:

  • Monocyte telomere shortening in type 2 diabetes may result from heightened oxidative DNA damage during cell division.
  • Shorter telomeres in monocytes may increase the risk of replicative senescence and vascular complications in type 2 diabetes.

Related Concept Videos

Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...